Cancer patients are often guided by social media influencers to quit traditional treatment, including basic chemotherapy, and ...
Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for ...
Patients and families from the University of Louisville Health Brown Cancer Center gathered for the third annual Hats for ...